Todisco Joseph 4

What Happened
Joseph Todisco, CEO of CorMedix Inc. (CRMD), received a grant of 225,900 restricted stock units (RSUs) on 2026-01-23 (reporting code A). As part of withholding to cover tax liabilities, 27,306 shares were surrendered/disposed at an effective price of $7.27 per share for approximately $198,515 (reporting code F).

Key Details

• Transaction date(s): 2026-01-23 (grant and tax withholding); Form 4 filed 2026-01-27.
• Award: 225,900 RSUs granted, recorded at $0.00 per share for acquisition purposes.
• Withholding: 27,306 shares withheld/disposed at $7.27 each, total ~$198,515.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: RSUs vest 1/4 on grant date and then 1/4 each on the first, second, and third anniversaries, subject to continued employment (see F1).
• Transaction codes: A = Award/Grant, F = Tax withholding (share surrender). No late-filing flag was indicated in the summary provided.

Context
RSUs are a form of compensation — they give the holder the right to receive shares once vested, rather than representing an open-market purchase. The withholding of 27,306 shares is a routine tax payment tied to the RSU grant (a common cashless withholding method) and should not be read as an independent sale decision about the company’s prospects.